Cocrystal Pharma Discusses Therapeutic Platform Applications and Progress with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (Nasdaq: COCP) (“the Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. CFO and co-interim CEO James (Jim) Martin joined Stock Day host Sever Copley. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Aug 3, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Cocrystal Pharma Discusses Therapeutic Platform Applications and Progress with The Stock Day Podcast

0:00 12:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 12 minutes long.

When was this Stock Day Media episode published?

This episode was published on August 3, 2022.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!